United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - ropinirole hydrochloride - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - ropinirole hydrochloride - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - ropinirole hydrochloride - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - ropinirole hydrochloride - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - ropinirole hydrochloride - oral tablet - 1mg

Israel - English - Ministry of Health

medison pharma ltd - safinamide as methanesulfonate - film coated tablets - safinamide as methanesulfonate 100 mg - safinamide - xadago is indicated for the treatment of adult patients with idiopathic parkinson’s disease (pd) as add-on therapy to a stable dose of levodopa (l-dopa) alone or in combination with other pd medicinal products in mid-to late-stage fluctuating patients.

Israel - English - Ministry of Health

medison pharma ltd - safinamide as methanesulfonate - film coated tablets - safinamide as methanesulfonate 50 mg - safinamide - xadago is indicated for the treatment of adult patients with idiopathic parkinson’s disease (pd) as add-on therapy to a stable dose of levodopa (l-dopa) alone or in combination with other pd medicinal products in mid-to late-stage fluctuating patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - amantadine hydrochloride, quantity: 100 mg - capsule, soft - excipient ingredients: titanium dioxide; glycerol; lecithin; sodium propyl hydroxybenzoate; yellow beeswax; partially hydrogenated soya oil; iron oxide red; gelatin; sodium ethyl hydroxybenzoate; hydrogenated soya oil; rape seed oil; maize starch; sorbitol; mannitol; ethyl acetate; butan-1-ol; shellac; industrial methylated spirit - parkinson's disease: idiopathic parkinson's disease; post encephalitic parkinsonism; symptomatic parkinsonism (e.g. following cns injury from carbon monoxide poisoning); arteriosclerotic parkinsonism; drug-induced extrapyramidal reactions. symmetrel can be given alone for initial therapy or combined with anticholinergic drugs or l-dopa (see "dosage and administration"). note: symmetrel is not indicated for the treatment of tardive dyskinesia. type a virus influenza: prophylaxis of respiratory tract illness caused by influenza type a. prophylaxis in non-immunized individuals (including children) for whom influenza may have serious consequences (e.g. persons with chronic respiratory disease of diabetes mellitus).

Singapore - English - HSA (Health Sciences Authority)

procter & gamble international operations sa singapore branch - cyanocobalamin; pyridoxine hydrochloride; thiamine hydrochloride - injection - 1 mg/3 ml - cyanocobalamin 1 mg/3 ml; pyridoxine hydrochloride 100 mg/3 ml; thiamine hydrochloride 100 mg/3 ml

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - budesonide 160ug equivalent to 200 µg metered dose; formoterol fumarate dihydrate 4.5ug equivalent to 6 µg metered dose - powder for inhalation - active: budesonide 160ug equivalent to 200 µg metered dose formoterol fumarate dihydrate 4.5ug equivalent to 6 µg metered dose excipient: lactose monohydrate - duoresp spiromax is indicated in the treatment of asthma to achieve overall asthma control, including the prevention and relief of symptoms as well as the reduction of the risk of exacerbations. duoresp spiromax is suitable for any asthma severity, where the use of inhaled corticosteroids is appropriate.